Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
Business Wire•05/08/2026•06:30 ET
0
Whiz Insights
Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
* Data from two positive Phase 3 trials demonstrated rapid onset of effect and durable benefit through at least 6 months, further validating COMP360’s potential to establish a new standard of care in TRD
Get started
Create a free account to read the full story.